Dr. Bridgette Blebu Secures R34 Grant to Address Preeclampsia Prevention in Black Immigrant Populations
Dr. Bridgette Blebu, an investigator at The Lundquist Institute, has been awarded a three-year R34 grant from the National Heart, Lung, and Blood Institute (NHLBI). This grant will fund early-stage research aimed at improving the delivery of evidence-based preeclampsia prevention, particularly focusing on Black immigrant populations in California. Preeclampsia, a serious pregnancy complication characterized by high blood pressure, affects approximately 1 in 10 pregnancies in the United States. Despite established evidence supporting interventions like daily low-dose aspirin to reduce its risk, these preventive approaches remain underutilized. Dr. Blebu's project will investigate the structural, clinical, and patient factors that influence risk identification, the integration of recommendations into routine workflows, and the support patients need after a prescription. The initial phase of the project involves building research partnerships with community clinics across Los Angeles County and conducting int...